Vytrus Biotech S.A.
Research Vytrus Biotech S.A. (VYT) on Bullrun: market cap EUR 139.05M, P/E 48.0. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerVYT
- ExchangeMC
- CountrySpain
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 139.05M
- P/E48.0
- Financial periodFY2025
- RevenueEUR 8.37M
- Revenue growth66.0%
- Net incomeEUR 2.90M
- Free cash flowEUR 1.22M
- Gross margin105.5%
Valuation Snapshot
latest market cap is EUR 139.05M; P/E is 48.0.
About Vytrus Biotech S.A.
Vytrus Biotech, S.A. develops, produces, and sells active ingredients from plant stem cells in Spain and internationally. It offers Clarivine that activates skin's regeneration processes; Quora Noni biomics for rejuvenating the skin microbiota; Deobiome Noni, a prebiotic deodorant to reduce the generation of body odour; Sarcoslim Re-Shape, an active ingredient to reduce fat on tissue; Capilia Longa that improves density in hair, eyebrows, and eyelashes;
Frequently asked questions
What is Vytrus Biotech S.A.'s market cap?
Vytrus Biotech S.A.'s market capitalization is EUR 139.05M.
What is Vytrus Biotech S.A.'s P/E ratio?
Vytrus Biotech S.A.'s price-to-earnings (P/E) ratio is 48.0.
What does Vytrus Biotech S.A. do?
Vytrus Biotech, S.A. develops, produces, and sells active ingredients from plant stem cells in Spain and internationally. It offers Clarivine that activates skin's regeneration processes; Quora Noni biomics for rejuvenating the skin microbiota;